Rufinamide
- Generic Name
- Rufinamide
- Brand Names
- Banzel, Inovelon
- Drug Type
- Small Molecule
- Chemical Formula
- C10H8F2N4O
- CAS Number
- 106308-44-5
- Unique Ingredient Identifier
- WFW942PR79
Overview
Rufinamide is a triazole derivative and an anticonvulsant medication to treat seizure disorders like Lennox-Gastuat syndrome, a form of childhood epilepsy. Clinical trials suggest its efficacy in the treatment of partial seizures.
Background
Rufinamide is a triazole derivative and an anticonvulsant medication to treat seizure disorders like Lennox-Gastuat syndrome, a form of childhood epilepsy. Clinical trials suggest its efficacy in the treatment of partial seizures.
Indication
治疗4岁以上及成人Lennox-Gastaut症候群的癫痫症。
Associated Conditions
- Lennox-Gastaut Syndrome
Clinical Trials
FDA Approved Products
RUFINAMIDE
Manufacturer:Micro Labs Limited
Route:ORAL
Strength:200 mg in 1 1
Approved: 2023/05/17
NDC:42571-391
Rufinamide
Manufacturer:Aurobindo Pharma Limited
Route:ORAL
Strength:200 mg in 1 1
Approved: 2022/12/06
NDC:59651-616
RUFINAMIDE
Manufacturer:Lupin Pharmaceuticals, Inc.
Route:ORAL
Strength:200 mg in 1 1
Approved: 2023/12/08
NDC:68180-803
RUFINAMIDE
Manufacturer:Lupin Pharmaceuticals, Inc.
Route:ORAL
Strength:400 mg in 1 1
Approved: 2023/12/08
NDC:68180-804
Rufinamide
Manufacturer:Aurobindo Pharma Limited
Route:ORAL
Strength:400 mg in 1 1
Approved: 2022/12/06
NDC:59651-617
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath